1. Home
  2. NCMI vs AVXL Comparison

NCMI vs AVXL Comparison

Compare NCMI & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCMI
  • AVXL
  • Stock Information
  • Founded
  • NCMI 2005
  • AVXL 2001
  • Country
  • NCMI United States
  • AVXL United States
  • Employees
  • NCMI N/A
  • AVXL N/A
  • Industry
  • NCMI Advertising
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NCMI Consumer Discretionary
  • AVXL Health Care
  • Exchange
  • NCMI Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • NCMI 666.3M
  • AVXL 779.5M
  • IPO Year
  • NCMI 2007
  • AVXL N/A
  • Fundamental
  • Price
  • NCMI $6.69
  • AVXL $8.35
  • Analyst Decision
  • NCMI Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • NCMI 4
  • AVXL 2
  • Target Price
  • NCMI $7.56
  • AVXL $44.00
  • AVG Volume (30 Days)
  • NCMI 384.1K
  • AVXL 995.5K
  • Earning Date
  • NCMI 03-17-2025
  • AVXL 02-12-2025
  • Dividend Yield
  • NCMI N/A
  • AVXL N/A
  • EPS Growth
  • NCMI N/A
  • AVXL N/A
  • EPS
  • NCMI N/A
  • AVXL N/A
  • Revenue
  • NCMI $245,300,000.00
  • AVXL N/A
  • Revenue This Year
  • NCMI $47.09
  • AVXL N/A
  • Revenue Next Year
  • NCMI $19.46
  • AVXL N/A
  • P/E Ratio
  • NCMI N/A
  • AVXL N/A
  • Revenue Growth
  • NCMI 47.68
  • AVXL N/A
  • 52 Week Low
  • NCMI $3.71
  • AVXL $3.25
  • 52 Week High
  • NCMI $7.60
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • NCMI 44.24
  • AVXL 40.39
  • Support Level
  • NCMI $6.90
  • AVXL $8.50
  • Resistance Level
  • NCMI $7.25
  • AVXL $9.20
  • Average True Range (ATR)
  • NCMI 0.23
  • AVXL 0.49
  • MACD
  • NCMI -0.03
  • AVXL -0.01
  • Stochastic Oscillator
  • NCMI 34.88
  • AVXL 32.23

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: